C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF13 Degrader

CCCC Stock  USD 2.79  0.10  3.46%   
About 68% of C4 Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding C4 Therapeutics suggests that many traders are alarmed. The current market sentiment, together with C4 Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use C4 Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved 36 Percent Overall Response Rate and 45 Percent Clinical Benefit Rate Responses Seen Across All Dose Levels Multiple Myeloma Arm Demonstrated Well-Tolerated Safety Profile On-Target Neutropenia Was Manageable With Low Rates of Febrile Neutropenia and Infections No Treatment Emergent Adverse Events Leading to Dose Reduction In Non-Hodgkins Lymphoma, Cemsidomide Monoth

Read at finance.yahoo.com
Yahoo News
  

C4 Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards C4 Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
59.7%
55.8%
62.0%
52.2%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

C4 Therapeutics Fundamental Analysis

We analyze C4 Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C4 Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C4 Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

C4 Therapeutics is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

C4 Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with C4 Therapeutics stock to make a market-neutral strategy. Peer analysis of C4 Therapeutics could also be used in its relative valuation, which is a method of valuing C4 Therapeutics by comparing valuation metrics with similar companies.

Peers

C4 Therapeutics Related Equities

STTKShattuck Labs   11.05   
0%
100.0%
RVMDRevolution Medicines   0.27   
0%
2.0%
ARVNArvinas   0.56   
5.0%
0%
GLUEMonte Rosa   1.03   
9.0%
0%
IPSCCentury Therapeutics   1.13   
10.0%
0%
FHTXFoghorn Therapeutics   1.16   
10.0%
0%
KYMRKymera Therapeutics   1.70   
15.0%
0%
CGEMCullinan Oncology   1.83   
16.0%
0%
NRIXNurix Therapeutics   2.31   
20.0%
0%
PRLDPrelude Therapeutics   2.89   
26.0%
0%
RZLTRezolute   3.46   
31.0%
0%
MLYSMineralys Therapeutics,   5.30   
47.0%
0%
EWTXEdgewise Therapeutics   7.35   
66.0%
0%

Complementary Tools for CCCC Stock analysis

When running C4 Therapeutics' price analysis, check to measure C4 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C4 Therapeutics is operating at the current time. Most of C4 Therapeutics' value examination focuses on studying past and present price action to predict the probability of C4 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C4 Therapeutics' price. Additionally, you may evaluate how the addition of C4 Therapeutics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
News Freq…Investor S…